Hiroshi Ikegami

Establishment of a Pancreatic β Cell Line That Retains Glucose-Inducible Insulin Secretion: Special Reference to Expression of Glucose Transporter Isoforms*

Jun‐ichi Miyazaki, Kimi Araki, Eiji Yamato et al. · Endocrinology · 1990 · 1.3K citations

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 300 citations

Non-pharmacological Intervention, Diabetes Management, Cardiovascular Disease +9

Pancreatic β Cell–specific Expression of  Thioredoxin, an Antioxidative and Antiapoptotic Protein, Prevents Autoimmune and Streptozotocin-induced Diabetes

Mizuo Hotta, Fumi Tashiro, Hiroshi Ikegami et al. · The Journal of Experimental Medicine · 1998 · 249 citations · Full text

Effect of two α-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms

Tomomi Fujisawa, Hiroshi Ikegami, Kaori Inoue et al. · Metabolism · 2005 · 245 citations

Obesity, Metabolic Syndrome, Diabetes Management +12

Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012)

Akihisa Imagawa, Toshiaki Hanafusa, Takuya Awata et al. · Journal of Diabetes Investigation · 2012 · 241 citations · Full text